Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $71.35B
Decision snapshot: AMPH stock price vs GM: inconclusive — current versus $50.48 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GM's multiple
Implied fair value · at AMPH's multiple
Needs AMPH P/E.
Live quote
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMPH FY 2025 (ended Dec 31, 2025) · GM FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 32% equity / 68% debt · EV / Revenue 1.07x · EV / EBITDA 10.49x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Amphastar Pharmaceuticals, Inc. · implied price per share
Bear
$44.56
Base
$52.42
Bull
$60.29
GENERAL MOTORS COMPANY · implied price per share
Bear
-$32.48
Base
-$38.21
Bull
-$43.94
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.06x
2.51x
Net debt / EBITDA
Leverage against operating earnings
-0.99x
6.71x
Cash and equivalents
Liquid reserves on the balance sheet
$282.81M
$26.91B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BRISTOL MYERS SQUIBB CO
AMPH vs BMY
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMPH vs TEVA
Bausch Health Companies Inc.
AMPH vs BHC
PERRIGO Co plc
AMPH vs PRGO
ANI PHARMACEUTICALS INC
AMPH vs ANIP
Ford Motor Company
AMPH vs F
Tesla, Inc.
AMPH vs TSLA
Rivian Automotive, Inc. / DE
AMPH vs RIVN
Lucid Group, Inc.
AMPH vs LCID
Nikola Corp
AMPH vs NKLA
Fisker Inc.
AMPH vs FSR
$43.70M
$153.19B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
